Article Text

Download PDFPDF
The Grading of Lymphovascular Space Invasion in Epithelial Ovarian Carcinoma
  1. Xueya Qian, PhD*,
  2. Xiaowei Xi, PhD* and
  3. Yubiao Jin, PhD
  1. * Departments of Obstetrics and Gynecology, and
  2. Pathology, Shanghai First People's Hospital Affiliated to Shanghai Jiao Tong University, Shanghai, China.
  1. Address correspondence and reprint requests to Xiaowei Xi, PhD, Department of Obstetrics and Gynecology, Shanghai First People's Hospital Affiliated to Shanghai Jiao Tong University, 85 Wujin Rd, Hongkou District, Shanghai, China 200080. E-mail:


Introduction: To assess the prognostic value of lymphovascular space invasion (LVSI) in epithelial ovarian carcinoma.

Methods: We reexamined single representative hematoxylin and eosin-stained sections of 66 patients with epithelial ovarian carcinoma to identify LVSI. A 4-grade system was used to classify LVSI: absent (no LVSI), mild (1-2 foci of LVSI), moderate (3-8 foci of LVSI), and severe (≥9 foci of LVSI). We investigated the possible associations between the grade of LVSI and clinicopathologic factors.

Results: Lymphovascular space invasion was present in 36 patients (54.5%) and absent in 30 (45.5%). Statistical analysis indicated that LVSI was significantly associated with advanced clinical stage, poor histological grade, and lymph node metastasis. Follow-up studies indicated that the disease-free survival time for patients without LVSI was significantly longer than that for patients with moderate LVSI (P = 0.01) and severe LVSI (P = 0.001). The overall survival (OS) time for patients with moderate or severe LVSI was significantly shorter than that for patients with mild or no LVSI. The grade of LVSI was found to be significantly associated with OS (P = 0.004). The grade of LVSI showed poor correlation with disease-free survival and OS.

Conclusions: The grade of LVSI is an important predictive factor for disease recurrence and poor survival of patients with epithelial ovarian carcinoma.

  • Lymphovascular space invasion
  • Epithelial ovarian carcinoma
  • Prognosis

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


  • The authors declare that there are no conflicts of interest.